Phase Forward Announces Fourth Quarter Financial Reporting Date for February 1, 2007.WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that it will release financial results for the quarter and year ended December 31, 2006 and hold a conference call with investors on Thursday, February 1, 2007. The Company plans to hold the investor conference call, hosted by Bob Weiler, president and chief executive officer, and Rodger Weismann, senior vice president and chief financial officer, to discuss its fourth quarter and full year 2006 financial results and its outlook for 2007. The call will be held on Thursday, February 1, 2007, at 5:00 p.m. (EST EST electroshock therapy. EST abbr. electroshock therapy ). The investor conference call will be available via live webcast on Phase Forward's web site at www.phaseforward.com under the tab "Investors." To participate by telephone, the domestic dial-in number is 866-770-7051 and the international dial-in is 617-213-8064. The access code is 72878354. Investors are advised to dial-in at least five minutes prior to the call to register. The webcast will be archived until Thursday, March 1, 2007. About Phase Forward Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm[TM]), clinical data management (Clintrial[TM]), clinical trials signal detection (CTSD CTSD Crew and Thermal Systems Division CTSD Certified Trading System Developer CTSD Computer Test Sequences Document (NASA) CTSD Coordinate Transformation System (NASA) CTSD Combat Training Support Directorate [TM]), strategic pharmacovigilance (WebVDME[TM] and Signal Management), adverse event reporting (Clintrace[TM]) and applied data standards (WebSDM[TM]). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization Process optimization is the practice of making changes or adjustments to a process, to get results. Optimization is the use of specific techniques to determine the most cost effective and efficient solution to a problem or design for a process. , safety data management and industry standards. Phase Forward's products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 260 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, , Dana-Farber Cancer Institute, Eli Lilly, Food and Drug Administration, GlaxoSmithKline, Merck, U.K. Medicines and Healthcare Products Regulatory Agency The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK government agency which is responsible for ensuring that medicines and medical devices work and are acceptably safe. , National Institutes of Health, Procter & Gamble, Quintiles Quintiles Transnational Corp. is a contract research organization which serves the pharmaceutical, biotechnology and healthcare industries. History Quintiles was founded in 1982 by Dennis Gillings and as of 2007 it has 18,000 employees. , sanofi-aventis, Schering-Plough Research Institute, Serono and Servier. Additional information about Phase Forward is available at www.phaseforward.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion